AsiaIntervention最新文献

{"title":"Overcoming cardiogenic shock and vascular access challenges with LAVA-ECMO.","authors":"Alvin H Y Ko, Michael Chiang, Ivan Wong, Angus Shing Fung Chui, Michael Kang-Yin Lee","doi":"10.4244/AIJ-D-24-00056","DOIUrl":"https://doi.org/10.4244/AIJ-D-24-00056","url":null,"abstract":"","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":"11 1","pages":"44-45"},"PeriodicalIF":0.0,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905091/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143671877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Initial experience with the Crea Aortic Valve System - a first-in-human study.","authors":"Carlos Calderas, Maurizio Taramasso, Jimmy Levy, Jose Rojas, Luane Piamo, Herman Rodriguez, George De Santolo, Marianela Reinaga, Flavio Ribichini, Kanchan V Bilgi","doi":"10.4244/AIJ-D-24-00023","DOIUrl":"10.4244/AIJ-D-24-00023","url":null,"abstract":"<p><strong>Background: </strong>Transcatheter aortic valve implantation (TAVI) is a minimally invasive option for severe aortic stenosis (AS). The Crea Aortic Valve (CAV) is a new self-expanding transcatheter aortic valve implant that has been successfully tested in preclinical studies.</p><p><strong>Aims: </strong>We aimed to assess the technical success, device performance, and early safety of the CAV System in a first-in-human study for the device in patients with severe AS.</p><p><strong>Methods: </strong>We prospectively evaluated the CAV using the Valve Academic Research Consortium (VARC)-3 criteria in three high-risk patients with severe AS. A computed tomography angiography and transthoracic echocardiographic (TTE) assessment were carried out, which was followed by TAVI according to standard protocol. TTE was performed before and after the procedure, before discharge, and at the 1- and 6-month clinical follow-ups to monitor the aortic valve area, the maximum velocity (Vmax), the mean (MG) and peak pressure gradients, and paravalvular leak (PVL).</p><p><strong>Results: </strong>The CAV was successfully implanted, using the cusp-overlap technique for patient 1 and the coplanar view for patients 2 and 3, with good usability of the delivery system for optimal positioning, reduction of the Vmax to <2 m/s and MG to <10 mmHg, and trivial PVL. An atrioventricular block necessitating a permanent pacemaker occurred in one patient. There was no incidence of stroke, heart failure, or renal failure at 6 months of follow-up.</p><p><strong>Conclusions: </strong>The CAV was implanted with success, and the system performed as intended as per VARC-3 criteria. The device should be evaluated in a larger clinical study for further efficacy and safety data.</p>","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":"11 1","pages":"52-59"},"PeriodicalIF":0.0,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905096/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143671874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Percutaneous device closure of a perimembranous ventricular septal defect in a 2-month-old infant.","authors":"Kalyan Munde, Anant Munde, Mohan Paliwal, Hariom Kolapkar, Anagh T Shetru","doi":"10.4244/AIJ-D-24-00038","DOIUrl":"10.4244/AIJ-D-24-00038","url":null,"abstract":"","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":"11 1","pages":"64-66"},"PeriodicalIF":0.0,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905105/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143671880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A real-world experience with a thin-strut bioresorbable vascular scaffold system: a single-centre study.","authors":"Puneet K Verma, Sanjeev Sroa, Paras Koushal","doi":"10.4244/AIJ-D-24-00033","DOIUrl":"10.4244/AIJ-D-24-00033","url":null,"abstract":"<p><strong>Background: </strong>Despite the significant advancements in interventional cardiology, there is a need for new, metal-free bioresorbable stent systems that preserve the vasomotor function of the treated vessel and decrease the risk of restenosis associated with metal stents and the risk of thrombosis associated with first-generation bioresorbable scaffolds.</p><p><strong>Aims: </strong>The aim of this study was to assess the safety and efficacy of the MeRes100 bioresorbable scaffold in complex <i>de novo</i> and in-stent restenotic coronary lesions.</p><p><strong>Methods: </strong>We conducted a retrospective single-centre study that included 86 patients with coronary artery disease who had been implanted with a next-generation MeRes100 sirolimus-eluting bioresorbable vascular scaffold system and followed up to 12 months after the procedure.</p><p><strong>Results: </strong>The scaffold was successfully delivered to the target lesion with satisfactory stent expansion in 98.84% of cases. Only one patient died, and the in-hospital mortality rate was as low as 1.16% (cardiac death). No cases of major adverse cardiac events, cardiac death, myocardial infarction, ischaemia-driven target lesion revascularisation, or scaffold thrombosis were reported during the follow-up.</p><p><strong>Conclusions: </strong>Our preliminary data suggest that the thin-strut sirolimus-eluting bioresorbable scaffold appears to be a clinically acceptable, safe, reliable and reproducible strategy to treat both <i>de novo</i> and in-stent restenotic coronary artery lesions. Long-term follow-up of a larger patient population is warranted.</p>","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":"11 1","pages":"26-34"},"PeriodicalIF":0.0,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905108/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143671789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Long-term safety and performance of the BioMime Morph sirolimus-eluting coronary stent system for very long coronary lesions in real-world settings.","authors":"Deepak Davidson, Mukul Misra, Sharad Chandra, Raghu Thagachagere Ramegowda, Bharat Bhushan Chanana, Shuvanan Ray, Keyur Parikh, Sanjeeb Roy, Rajendra Kumar Jain, Sivakumar Rathnavel, Viji Samuel Thomson, Rajalekshmi Subramanian, Pannala Lakshmi Narasimha Kapardhi, Ganesan Manohar, Rajesh Thachathodiyl, Raja Sekhar Varma, Arun Kumar Chopra, Jagdish S Hiremath, Manojkumar Bhavarilal Chopada, Ashokkumar Thakkar","doi":"10.4244/AIJ-D-24-00008","DOIUrl":"10.4244/AIJ-D-24-00008","url":null,"abstract":"<p><strong>Background: </strong>Long stents reduce the risk for in-stent restenosis associated with percutaneous coronary interventions in long, tapered coronary lesions.</p><p><strong>Aims: </strong>The Morph India study investigated the long-term safety and clinical performance of the BioMime Morph sirolimus-eluting stent (SES), a tapered stent used for treating long coronary lesions.</p><p><strong>Methods: </strong>This is a prospective, multicentre, single-arm, real-world, post-marketing surveillance study conducted among patients with long coronary lesions (length >26 mm to ≤56 mm, reference vessel diameter 2.25-3.50 mm) implanted with the BioMime Morph SES. The primary endpoint was freedom from target lesion failure (TLF). The incidence of target vessel failure (TVF) - defined as a composite of cardiac death related to the target vessel, target vessel myocardial infarction (TVMI), and ischaemia-driven target vessel revascularisation (ID-TVR) - was the secondary endpoint. An angiographic follow-up was conducted at 9 months, and subjects were followed up for 3 years.</p><p><strong>Results: </strong>Out of 448 enrolled patients, 420 patients completed the 3-year follow-up. The rate of freedom from TLF was 99.31% at 12 months and 98.80% at 3 years. In 3 years, there were 4 events each of TVMI, TVR (including ID-TVR) and ischaemia-driven target lesion revascularisation (all 0.95%). Quantitative coronary angiography analysis at a mean of 9.2 months revealed in-segment late lumen loss (LLL) of 0.29±0.23 mm and in-device LLL of 0.35±0.11 mm. The in-device minimal lumen diameter improved from 0.63±0.42 mm at preprocedure to 2.13±0.37 mm (p<0.001) at 9.2 months.</p><p><strong>Conclusions: </strong>The 3-year safety and clinical outcomes of BioMime Morph SES for treating long coronary lesions were satisfactory. Further long-term comparative studies are necessary to validate these results.</p>","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":"11 1","pages":"14-25"},"PeriodicalIF":0.0,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905104/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143671875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Commissural malalignment of degenerated surgical prosthesis and risk of coronary occlusion following TAVI: implications for BASILICA and coronary protection.","authors":"Abdul Hakeem, Babar Hasan, Asad Pathan","doi":"10.4244/AIJ-D-24-00001","DOIUrl":"https://doi.org/10.4244/AIJ-D-24-00001","url":null,"abstract":"","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":"11 1","pages":"60-61"},"PeriodicalIF":0.0,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905099/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143671794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Drug-coated balloons - a promising technology that needs more understanding!","authors":"Sankardas Ajit Mullasari, Vijayakumar Subban","doi":"10.4244/AIJ-E-25-00001","DOIUrl":"10.4244/AIJ-E-25-00001","url":null,"abstract":"","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":"11 1","pages":"12-13"},"PeriodicalIF":0.0,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905107/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143671872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Optical coherence tomography image with the three circles sign caused by the Z-shape phenomenon.","authors":"Ryoichi Miyazaki, Tetsumin Lee, Masakazu Kaneko, Yasutoshi Nagata, Toshihiro Nozato, Takashi Ashikaga","doi":"10.4244/AIJ-D-24-00035","DOIUrl":"10.4244/AIJ-D-24-00035","url":null,"abstract":"","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":"11 1","pages":"50-51"},"PeriodicalIF":0.0,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905100/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143671876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Recanalisation of a chronic total occlusion in a left circumflex artery using a steerable microcatheter.","authors":"Shinichiro Masuda, Naoki Masuda, Kotaro Kagiyama, Keiichi Kohashi, Yoshiaki Shintani, Shuzou Tanimoto, Nobuhiko Ogata, Takaaki Isshiki","doi":"10.4244/AIJ-D-24-00047","DOIUrl":"10.4244/AIJ-D-24-00047","url":null,"abstract":"","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":"11 1","pages":"46-47"},"PeriodicalIF":0.0,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905089/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143671882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"\"Distal radial first\": feasibility and safety for coronary angiography and PCI in Australia.","authors":"Samantha L Saunders, Sanjeev J Casinader, Ritin S Fernandez, Kelly M Easey, Eunice Chuah, Adam R Perkovic, Shubhang Hariharan, David Scott, Philopatir Mikhail, Christian Said, Roberto Spina, Austin N May, Andrew Boyle, Thomas J Ford","doi":"10.4244/AIJ-D-24-00036","DOIUrl":"10.4244/AIJ-D-24-00036","url":null,"abstract":"<p><strong>Background: </strong>Distal transradial artery (dTRA) access offers benefits to patients and operators.</p><p><strong>Aims: </strong>We sought to determine the feasibility and safety of the dTRA as a first-line vascular access site and to evaluate predictors of dTRA approach success.</p><p><strong>Methods: </strong>This retrospective cohort study analysed consecutive patients from three Australian centres who underwent coronary angiography and percutaneous coronary intervention via the dTRA (from November 2019 to December 2023). The primary outcome was procedural success (completion of a case using the dTRA puncture site). Secondary outcomes were access site crossover, procedural safety, arterial patency at follow-up, and predictors of procedural success.</p><p><strong>Results: </strong>A total of 1,692 patients were included (mean age 70.6±10.5 years, 59% male [n=993], mean body mass index [BMI] 31.0±7.0 kg/m², right dTRA 85%, ultrasound guidance 99%). First pass success was achieved in 92.2% (n=1,560) of patients, and 1.5% had success on the second puncture of the ipsilateral dTRA. Crossover was required in 6.3% (n=107; proximal transradial [n=78; 4.6%], contralateral dTRA [n=22; 1.3%], femoral [n=6; 0.4%], ulnar [n=1; 0.1%]). There were no major vascular complications. Access site bleeding requiring treatment occurred in 0.3% (n=5) of cases. Proximal and distal radial occlusion occurred in 0.1% and 0.4%, respectively. Thirty-day major adverse cardiovascular events occurred in 1.4% (n=24). Radial artery patency was 98% (630/641) at follow-up. Hypertension (odds ratio [OR] 1.73; p=0.029), an experienced operator (attending/consultant and ≥4 years' experience with dTRA; OR 2.80; p<0.001), and a low BMI (OR 1.48 per 10 unit decrease in BMI; p=0.012) were predictors of technical success.</p><p><strong>Conclusions: </strong>The \"distal radial first\" approach is feasible and safe for coronary procedures. Factors associated with procedural success include increased operator experience, a low BMI, and hypertension.</p>","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":"11 1","pages":"35-43"},"PeriodicalIF":0.0,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905101/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143671785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}